Tata Chemicals (TATACHEM) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
9 Jul, 2026Executive summary
Global demand for key products remains flat in the near term, with robust demand in India and Asia (excluding China), but weakness in China and Southeast Asia due to oversupply and high inventories.
Medium- to long-term outlook is positive, driven by solar PV and EV growth and sustainability applications, despite short-term margin challenges and ongoing geopolitical and tariff risks.
Operational highlights include strong standalone performance in India, reconfiguration and cessation of operations in the UK, and shipment delays in Kenya now resolved.
Board approved unaudited consolidated and audited standalone financial results for Q2 and H1 FY2026, with results published and available online.
Board approved fund raising via non-convertible debentures (NCDs) up to ₹1,500 crore on a private placement basis.
Financial highlights
Standalone revenue from operations up 19% year-over-year; EBITDA up 67%; profit after tax up 80%.
Consolidated revenue for Q2FY26 was ₹3,877 crore, down from ₹3,999 crore in Q2FY25; H1FY26 revenue was ₹7,596 crore, down from ₹7,788 crore in H1FY25.
EBITDA for Q2FY26 was ₹537 crore, down from ₹618 crore in Q2FY25; H1FY26 EBITDA was ₹1,186 crore, nearly flat year-over-year.
Net profit for Q2 FY2026 stood at ₹154 crore, compared to ₹316 crore in Q1 FY2026 and ₹267 crore in Q2 FY2025.
Consolidated EBITDA and profit after tax impacted by one-time provisions (INR 65 crore in UK, $5 million underabsorption in US), totaling INR 105 crore.
Outlook and guidance
Soda Ash prices expected to remain subdued and range-bound for the rest of the year due to oversupply and high Chinese inventories.
UK operations expected to turn positive in Q3 and Q4 FY 2026 as reconfiguration completes and focus shifts to value-added products.
Indian margins expected to stabilize, with anti-dumping duty providing support; volumes to remain strong.
Medium-term industry normalization anticipated as global capacity reconfiguration progresses.
Pricing pressure anticipated to persist in the short term, impacting margins.
Latest events from Tata Chemicals
- FY25 profit declined on lower realisation and UK impairments; dividend of ₹11.00 proposed.TATACHEM
Q4 24/258 Jul 2026 - Soda ash oversupply and weak prices drove losses, but India and expansions support future growth.TATACHEM
Q3 25/268 Jul 2026 - Net loss of ₹1,715 crore driven by US impairment, but leverage low and dividend maintained.TATACHEM
Q4 25/264 May 2026 - Revenue and profit fell on low prices and UK closure; net debt and risks increased.TATACHEM
Q3 24/253 Feb 2026 - Sequential revenue and EBITDA growth, but year-over-year declines amid European market headwinds.TATACHEM
Q1 24/252 Feb 2026 - Q2 FY25 revenue ₹3,999 crore, net profit ₹267 crore, expansions ramping up post-rains.TATACHEM
Q2 24/2519 Jan 2026 - Q1 FY26 saw higher profit and margins despite flat demand and global oversupply.TATACHEM
Q1 25/2625 Jul 2025